Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Universal Ibogaine has appointed Nick Karos as CEO on an interim basis, effective immediately.
  • Mr. Karos is a seasoned financier whose career has included senior roles with several US investment banks
  • Mr. Karos remains a short-listed candidate for the permanent position
  • Universal Ibogaine is a life sciences company researching medicalized ibogaine-centred addiction care
  • Universal Ibogaine Inc. (IBO) opened trading at C$0.14 per share

Universal Ibogaine (IBO) has appointed Nick Karos as CEO on an interim basis, effective immediately. 

Mr. Karos is based in Los Angeles, USA, and is a seasoned financier. His career includes senior roles with several US investment banks and most recently as CEO of Private Trading Group, which has provided business development and capital raising services for several successful start-up ventures.

Nick Karos sat down with Caroline Egan to discuss the appointment.

“I’m very excited to work with the talented partners at UI to move towards our goal of conducting clinical trials with Health Canada. Universal Ibogaine’s goal is to transform the addiction treatment model using ibogaine as the cornerstone of our new addiction treatment protocol. Addiction is a disease that affects society like none other, and we believe our ground-breaking protocol will give patients and families a better path towards long-term recovery.”

The board will immediately begin an executive search process for selecting a new CEO. Mr. Karos remains a short-listed candidate for the permanent position.

Universal Ibogaine is a life sciences company with a mission to research and deliver medicalized ibogaine-centred addiction care.

Universal Ibogaine Inc. (IBO) opened trading at C$0.14 per share.

More From The Market Herald
Rakovina Therapeutics Inc. (TSXV:RKV) - Executive Chairman- Jeffrey Bacha.

" Rakovina (TSXV:RKV) advancing trial programs for cancer treatment

Rakovina Therapeutics (RKV) is advancing its programs for malignant tumour treatment therapies.

" Top 5 Stories of the Week: RevoluGROUP (TSXV:REVO), Tenet Fintech (CSE:PKK), HIVE Blockchain (TSXV:HIVE), PyroGenesis (TSX:PYR), Nano One (TSX:NANO)

The week in markets is ending with fears of an imminent recession, except in Canada.

" Top 5 Stories of the Week: Givex Information Technology Group (TSX:GIVX), Nextech AR Solutions (CSE:NTAR) (OTCQB:NEXCF), Else Nutrition (TSX:BABY), Banyan Gold (TSXV:BYN), Trillion Energy (CSE:TCF)

One dilemma facing investors in the stock market is whether to increase, decrease or suspend their investment when inflation is continuously rising.

" Top 5 Stories of the Week: Saturn Oil & Gas (TSXV:SOIL), Trillion Energy (CSE:TCF), Siyata Mobile (NASDAQ:SYTA), Collective Mining (TSXV:CNL), Blackrock Silver (TSXV:BRC)

The downturn in the markets this week could benefit from some context.